Interleukin 12 and Its Effects on Tumor Growth in Mice
Author Information
Author(s): C Vizier, A Rosato, F Calderazzo, L Quintieri, P Fruscella, R Wainstok de Calmanovici, A Mantovani, A Vecchi, P Zanovello, D Collavol
Primary Institution: University of Padua
Hypothesis
Does interleukin 12 treatment enhance the immune response against H5V-induced tumors in mice?
Conclusion
Interleukin 12 treatment inhibits tumor growth but does not increase anti-tumor cytotoxic T-lymphocyte activity.
Supporting Evidence
- IL-12 treatment significantly decreased the size of primary tumors.
- High doses of IL-12 were required for effective tumor elimination.
- Anti-IFN-y treatment abrogated the anti-tumor effect of IL-12.
Takeaway
This study found that a treatment called interleukin 12 can help stop tumors from growing in mice, but it doesn't make the immune system fight the tumors better.
Methodology
Mice were injected with H5V cells and treated with different doses of interleukin 12, followed by monitoring tumor growth and immune response.
Limitations
The study primarily focused on one type of tumor in mice, which may not fully represent human cancer responses.
Participant Demographics
C57BL/6 and BALB/C mice, female, 8-12 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website